EY Announces Jim Sullivan of NWN Carousel as an Entrepreneur of The Year® 2022 Award Finalist
BOSTON–(BUSINESS WIRE)–Ernst & Young LLP (EY US) announced that NWN Carousel’s President & CEO, Jim…
BOSTON–(BUSINESS WIRE)–Ernst & Young LLP (EY US) announced that NWN Carousel’s President & CEO, Jim…
Connect Invest’s alternative investment platform to fill the gap LAS VEGAS–(BUSINESS WIRE)–Connect Invest, an alternative…
For the first time in the challenge’s history, Wageningen University & Research replaced all high-pressure…
Bi-directional charging enables power flow between the power grid and the car, allowing for integration…
The joint technology and go to market agreement will help customers accelerate their digital transformation…
NEW YORK & LONDON–(BUSINESS WIRE)–Morrow Sodali, the global shareholder engagement and ESG consulting firm, today…
First quarter revenues of €6.4 billion1, net income of €3.7 billion and fully diluted earnings per share…
RESEARCH TRIANGLE PARK, N.C., May 09, 2022 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq:…
Roermond, Netherlands–(Newsfile Corp. – May 9, 2022) – Reflex Finance, a hyper-deflationary token running on…
New Delhi, India, May 9, 2022 – (ACN Newswire) – India played host to one…
BOSTON–(BUSINESS WIRE)–Gelesis (NYSE: GLS), the maker of Plenity® for weight management, today announced that the…
PALO ALTO, Calif. & LONDON–(BUSINESS WIRE)–Babylon (NYSE: BBLN) today announced that Ali Parsa, Founder and…
PALO ALTO, Calif.–(BUSINESS WIRE)–Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), will conduct its…
Company heads to ACT Expo with 6th generation platform featuring new Motiv co-designed Nidec motor…
Strategic distribution agreement leverages a leading IT security solutions distributor’s expertise to cover the Indian…
DUBLIN–(BUSINESS WIRE)–The “United States Cold Chain Logistics Market – Growth, Trends, COVID-19 Impact, and Forecasts…
ORION CORPORATION PRESS RELEASE 9 May 2022 at 10.00 EEST The negotiations under the Act…
Oslo (Norway), 9 May 2022 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing…
Trial did not demonstrate efficacy on the key clinical endpoints Oxurion to focus on its…
Abstract supports ongoing Phase 3 program and planned NDA submission LONDON and RALEIGH, N.C., May…